Related Experiment Video
Updated: May 18, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
A case series of Bacillus cereus septicemia in patients with hematological disease
Yoshihito Uchino1, Noriyoshi Iriyama, Ken Matsumoto
1Department of Hematology and Rheumatology, Nihon University School of Medicine, Itabashi Hospital, Japan.
Insights
Bacillus cereus septicemia in hematologic patients can be fatal. Early antibiotics, vancomycin, and quinolones are key, while clindamycin and imipenem may be ineffective. Central venous catheters are a common source.
Area of Science:
- Hematology
- Infectious Diseases
- Microbiology
Background:
- Bacillus cereus (B. cereus) septicemia poses a life-threatening risk to patients with hematologic diseases.
- Optimal treatment strategies remain elusive due to limited clinical data.
Observation:
- A retrospective analysis of 13 B. cereus septicemia cases in 12 hematologic patients (2001-2010).
- Antibiotic susceptibility of B. cereus strains was evaluated.
- Central venous (CV) catheter cultures were performed in a subset of patients.
Findings:
- Four out of 12 patients died. Fatal outcomes were associated with delayed antibiotic administration (>24 hours), liver dysfunction, and central nervous system (CNS) involvement.
- All strains were susceptible to vancomycin and quinolones (ciprofloxacin, levofloxacin).
- High resistance rates were observed for clindamycin (76.9%) and imipenem (30.8%).
- B. cereus frequently originated from CV catheters, with positive cultures in 3 of 7 analyzed.
Implications:
- Carbapenems and clindamycin are likely inappropriate for treating B. cereus infections in this population.
- Prompt administration of effective antibiotics like vancomycin or quinolones is crucial.
- Vigilance in monitoring antibiotic susceptibility and meticulous CV catheter care are essential for managing B. cereus septicemia in hematologic patients.
Objective:
Bacillus cereus (B. cereus) septicemia is a cause of life-threatening infection in patients with hematologic diseases. However, preventing a fatal prognosis in patients with B. cereus infection has not yet been achieved due to insufficient clinical investigations. To discover more optimal treatment strategies, we analyzed B. cereus septicemia in patients with hematologic diseases.
Methods:
At our institution, we observed 13 cases of B. cereus septicemia in 12 patients with hematologic diseases between January 2001 and September 2010. The susceptibility of B. cereus strains to antibiotics was also analyzed.
Results:
Of 12 patients, four died of B. cereus septicemia. In this study, the delayed administration of appropriate antibiotics (starting >24 hours after presentation), the presence of liver dysfunction and evidence of central nervous system (CNS) involvement tended to result in a fatal prognosis. All of the bacterial strains were found to be susceptible to vancomycin and quinolones (such as ciprofloxacin and levofloxacin), whereas many strains were resistant to clindamycin (76.9%) and imipenem (30.8%). In seven of 10 patients, central venous (CV) catheter tips were removed and routinely cultured. Catheter tip cultures were positive for B. cereus in three of seven patients.
Conclusion:
Although not specific to B. cereus bacteremia, patients who died of B. cereus tended to present with CNS symptoms and/or liver dysfunction. Our clinical data suggested that carbapenem and clindamycin are no longer appropriate choices for treating B. cereus. In addition, B. cereus septicemia was found to frequently originate from CV catheters. Constant attention must be paid to update assessments of antibiotic susceptibility and careful management must be applied to CV catheters in patients with hematologic diseases.
Related Concept Videos
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction
Viral Meningitis
Investigation of Disease Outbreaks
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction